Home Cart Sign in  
Chemical Structure| 867331-82-6 Chemical Structure| 867331-82-6

Structure of TG 100801
CAS No.: 867331-82-6

Chemical Structure| 867331-82-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TG 100801 is the prodrug of TG 100572, which is a multi-targeted kinase inhibitor that inhibit select growth factor receptor tyrosine kinases and Src family kinases with IC50 values of 2/7/2/1/0.5 nM of VEGFR1/VEGFR2/FGFR1/Src/Fyn kianse respectively.

Synonyms: TG 100801

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TG 100801

CAS No. :867331-82-6
Formula : C33H30ClN5O3
M.W : 580.08
SMILES Code : CC1=CC(=CC2=C1N=C(NC1=CC=C(OCCN3CCCC3)C=C1)N=N2)C1=C(Cl)C=CC(OC(=O)C2=CC=CC=C2)=C1
Synonyms :
TG 100801
MDL No. :MFCD16038901

Safety of TG 100801

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of TG 100801

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00509548 Macular Degeneration ... More >> Choroidal Neovascularization Less << Phase 2 Terminated - United States, Arizona ... More >> Retina Centers, PC Tucson, Arizona, United States, 85704 United States, California Retina-Vitreous Associates Medical Group Beverly Hills, California, United States, 90211 United States, Florida Center for Retina and Macular Disease Winter Haven, Florida, United States, 33880 United States, Massachusetts Ophthalmic Consultants of Boston Boston, Massachusetts, United States, 02114 United States, New York Vitreous-Retina-Macula Consultants of New York New York, New York, United States, 10022 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, South Dakota Black Hills Regional Eye Institute Rapid City, South Dakota, United States, 57701 United States, Texas Vitreoretinal Consultants Houston, Texas, United States, 77030 Less <<
NCT00414999 Macular Degeneration ... More >> Diabetic Retinopathy Less << Phase 1 Completed - United States, Kansas ... More >> Quintiles Phase One Services, Inc. Lenexa, Kansas, United States, 66219 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.62mL

1.72mL

0.86mL

17.24mL

3.45mL

1.72mL

References

 

Historical Records

Categories